Anubis Barcelona Concentrate
NDC Package 83021-617-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Anubis Barcelona (peg-40 hydrogenated castor oil, propylene glycol, allantoin) concentrates is classified as a

administered via topical route. This formulation utilizes a concentrate delivery system. Marketed by Anubis Cosmetics Sl, this product is identified by NDC 83021-617 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
83021-617-05
Package Description
5 mL in 1 VIAL, GLASS
Product Code
83021-617
11-Digit Billing Format
83021061705

Clinical Specifications

Proprietary Name
Anubis Barcelona
Non-Proprietary Name
Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin
Substance Name
Alcohol; Allantoin; Arctium Lappa Root; Ascorbyl Palmitate; Butylparaben; Citral; Ethylparaben; Farnesol; Fd&c Yellow No. 5; Fragrance 13576; Hydroxyethyl Cellulose, Unspecified; Isopropyl Alcohol; Levomenol; Limonene, (+)-; Methylparaben; Niacinamide; Panthenol; Phenoxyethanol; Polyoxyl 40 Hydrogenated Castor Oil; Powdered Cellulose; Propylene Glycol; Propylparaben; Riboflavin; Tioxolone; Tocopherol; Water; Yeast, Unspecified
Dosage Form
Concentrate - A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Anubis Cosmetics Sl
Product Type
Human Otc Drug
FDA Application #
M006
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-21-2022
End Marketing Date
09-20-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83021-617-05 identifies a specific commercial package of 5 ml in 1 vial, glass of Anubis Barcelona, a human over the counter drug labeled by Anubis Cosmetics Sl. This concentrate is formulated for topical use and contains alcohol; allantoin; arctium lappa root; ascorbyl palmitate; butylparaben; citral; ethylparaben; farnesol; fd&c yellow no. 5; fragrance 13576; hydroxyethyl cellulose, unspecified; isopropyl alcohol; levomenol; limonene, (+)-; methylparaben; niacinamide; panthenol; phenoxyethanol; polyoxyl 40 hydrogenated castor oil; powdered cellulose; propylene glycol; propylparaben; riboflavin; tioxolone; tocopherol; water; yeast, unspecified as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anubis Cosmetics Sl on October 21, 2022.

How is this Anubis Cosmetics Sl product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83021061705. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83021-617-05
11-Digit CMS (5-4-2)
83021-0617-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.